Biotechnology Market Research Reports & Industry Analysis
Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.
Biotech Market Research to Fuel Business Growth
Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:
- Current market performance, industry outlooks, and industry lifecycles
- Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
- Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
- Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies
Stay Ahead with our Biotechnology Industry Analysis
The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.
Biotechnology Industry Research & Market Reports
-
Biochemical Reagents
... CAGR of 8.7% over the analysis period 2024-2030. PCR Reagent Kits, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$6.3 Billion by the end of the ... Read More
-
Biologics
... 8.2% over the analysis period 2024-2030. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$271.3 Billion by the end of the analysis period. ... Read More
-
Biotech Flavors
... CAGR of 6.7% over the analysis period 2024-2030. Vanilla & Vanillin, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$872.9 Million by the end of the ... Read More
-
Bone Morphogenetic Proteins
... at a CAGR of 2.4% over the analysis period 2024-2030. Recombinant human bone morphogenetic protein-2 (rhBMP-2), one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$484.6 Million ... Read More
-
Biotech Business April 2025
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
Pharma And Biotech CRM Software Global Market Report 2025
... and biotech crm software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Worldwide Biotech April 2025
... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry. Read More
-
Human Augmentation
... CAGR of 18.8% over the analysis period 2024-2030. Wearable, one of the segments analyzed in the report, is expected to record a 17.9% CAGR and reach US$564.2 Billion by the end of the analysis period. ... Read More
-
In Situ Hybridization (ISH)
... 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Fluorescence In Situ Hybridization (FISH), one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.1 ... Read More
-
Monoclonal Antibodies
... CAGR of 6.7% over the analysis period 2024-2030. Human, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$105.2 Billion by the end of the analysis period. ... Read More
-
Biotechnology Instrumentation
... CAGR of 5.4% over the analysis period 2024-2030. Immunoassay Systems, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$26.1 Billion by the end of the analysis ... Read More
-
Gene Therapy
... CAGR of 23.0% over the analysis period 2024-2030. Viral, one of the segments analyzed in the report, is expected to record a 23.3% CAGR and reach US$5.5 Billion by the end of the analysis period. ... Read More
-
2025 Global Gene Therapy Cell Culture Medias Market Industry (2031 Outlook)
... size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market ... Read More
-
2025 Global Gene Therapy For Age-Related Macular Degeneration Market Industry (2031 Outlook)
... market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, ... Read More
-
Bio/Pharmaceutical Outsourcing Report, March 2025
... outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing ... Read More
-
Anti GM-CSF Antibody - Pipeline Insight, 2025
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Anti-CD28 Antibody - Pipeline Insight, 2025
... for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental Stages Clinical ... Read More
-
Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
... Kalorama Information explores the transformative potential of cell and gene therapies in modern medicine. These therapies offer groundbreaking treatments by addressing genetic causes of diseases and modulating the immune system. The report highlights the surge ... Read More
-
2025 Global Gene Expression Analysis Market Industry (2031 Outlook)
... for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, market trends, technology ... Read More
-
Syndromic Multiplex Diagnostic Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... to the high number of COVID-19 cases in the early stages of the pandemic, hospitals worldwide canceled medical visits, and the target population remained indoors fearing infection. Research and development efforts increased for advanced Molecular ... Read More
-
Cell-free Protein Expression Market Report by Product (Expression Systems, Reagents), Method (Transcription and Translation Systems, Translation Systems), Application (Enzyme Engineering, High Throughput Production, Protein Labeling, Protein-Protein Interaction, Protein Purification), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others), and Region 2025-2033
... 2025-2033. The market is experiencing significant growth mainly driven by advancements in personalized medicine, vaccine development, and synthetic biology. The rising demand for cost-effective, flexible solutions in pharmaceuticals and biotechnology further propels market growth, positioning ... Read More
-
20s Proteasome Inhibitor - Pipeline Insight, 2025
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Anti-CD274 (PD-L1) Antibody - Pipeline Insight, 2025
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Gene Panel
... CAGR of 19.6% over the analysis period 2024-2030. Testing Services, one of the segments analyzed in the report, is expected to record a 22.1% CAGR and reach US$3.9 Billion by the end of the analysis ... Read More
Research Assistance
